{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:30:29Z","timestamp":1791721829382,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12020-021-02616-1","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T15:02:58Z","timestamp":1611414178000},"page":"203-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of less severe hypercortisolism in fractured patients admitted in an outpatient clinic for metabolic bone diseases"],"prefix":"10.1007","volume":"73","author":[{"given":"F.","family":"Pugliese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Salcuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Columbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Velluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Giovanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eller-Vainicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9954-4187","authenticated-orcid":false,"given":"A.","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"2616_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0889-8529(05)70115-8","volume":"29","author":"M Reincke","year":"2000","unstructured":"M. Reincke, Subclinical Cushing\u2019s syndrome. Endocrinol. Metab. Clin. N. Am. 29, 43\u201356 (2000). https:\/\/doi.org\/10.1016\/s0889-8529(05)70115-8","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"2616_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1210\/jc.2010-2722","volume":"96","author":"I Chiodini","year":"2011","unstructured":"I. Chiodini, Clinical review: diagnosis and treatment of subclinical hypercortisolism. J. Clin. Endocrinol. Metab. 96, 1223\u20131236 (2011). https:\/\/doi.org\/10.1210\/jc.2010-2722","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2616_CR3","doi-asserted-by":"publisher","first-page":"R265","DOI":"10.1530\/EJE-16-0289","volume":"175","author":"I Chiodini","year":"2016","unstructured":"I. Chiodini, C.E. Vainicher, V. Morelli, S. Palmieri, E. Cairoli, A.S. Salcuni, M. Copetti, A. Scillitani, Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review. Eur. J. Endocrinol. 175, R265\u2013R282 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0289","journal-title":"Eur. J. Endocrinol."},{"key":"2616_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1210\/jcem.86.2.7178","volume":"86","author":"G Osella","year":"2001","unstructured":"G. Osella, G. Reimondo, P. Peretti, A. Al\u00ec, P. Paccotti, A. Angeli, M. Terzolo, The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. J. Clin. Endocrinol. Metab. 86, 604\u2013607 (2001). https:\/\/doi.org\/10.1210\/jcem.86.2.7178","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2616_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2169\/internalmedicine.53.1489","volume":"53","author":"A Arduc","year":"2014","unstructured":"A. Arduc, B.A. Dogan, G. Akbaba, I. Dagdelen, K. Kucukler, S. Isik, U. Ozuguz, D. Berker, S. Guler, A rare presentation of subclinical Cushing\u2019s syndrome as a pubic fracture. Intern. Med. 53, 1779\u20131782 (2014). https:\/\/doi.org\/10.2169\/internalmedicine.53.1489","journal-title":"Intern. Med."},{"key":"2616_CR6","first-page":"341","volume":"67","author":"V Khanine","year":"2000","unstructured":"V. Khanine, J.J. Fournier, E. Requeda, J.P. Luton, F. Simon, J. Crouzet, Osteoporotic fractures at presentation of Cushing\u2019s disease: two case reports and a literature review. Jt. Bone Spine 67, 341\u2013345 (2000)","journal-title":"Jt. Bone Spine"},{"key":"2616_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-147-8-200710160-00006","volume":"147","author":"I Chiodini","year":"2007","unstructured":"I. Chiodini, M.L. Mascia, S. Muscarella, C. Battista, S. Minisola, M. Arosio, S.A. Santini, G. Guglielmi, V. Carnevale, A. Scillitani, Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann. Intern. Med. 147, 541\u2013548 (2007). https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00006","journal-title":"Ann. Intern. Med."},{"key":"2616_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s100670170099","volume":"20","author":"P Kann","year":"2001","unstructured":"P. Kann, M. Laudes, B. Piepkorn, A. Heintz, J. Beyer, Suppressed levels of serum cortisol following high-dose oral dexamethasone administration differ between healthy postmenopausal females and patients with established primary vertebral osteoporosis. Clin. Rheumatol. 20, 25\u201329 (2001). https:\/\/doi.org\/10.1007\/s100670170099","journal-title":"Clin. Rheumatol."},{"key":"2616_CR9","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1210\/jc.2002-020275","volume":"87","author":"C Tannenbaum","year":"2002","unstructured":"C. Tannenbaum, J. Clark, K. Schwartzman, S. Wallenstein, R. Lapinski, D. Meier, M. Luckey, Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J. Clin. Endocrinol. Metab. 87, 4431\u20134437 (2002). https:\/\/doi.org\/10.1210\/jc.2002-020275","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2616_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1530\/EJE-13-0102","volume":"169","author":"C Eller-Vainicher","year":"2013","unstructured":"C. Eller-Vainicher, E. Cairoli, V.V. Zhukouskaya, V. Morelli, S. Palmieri, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Prevalence of subclinical contributors to low bone mineral density and\/or fragility fracture. Eur. J. Endocrinol. 169, 225\u2013237 (2013). https:\/\/doi.org\/10.1530\/EJE-13-0102","journal-title":"Eur. J. Endocrinol."},{"key":"2616_CR11","first-page":"352","volume":"18","author":"A Lasco","year":"2014","unstructured":"A. Lasco, A. Catalano, A. Pilato, G. Basile, A. Mallamace, M. Atteritano, Subclinical hypercortisol-assessment of bone fragility: experience of single osteoporosis center in Sicily. Eur. Rev. Med. Pharmacol. Sci. 18, 352\u2013358 (2014)","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"2616_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.berh.2009.09.006","volume":"23","author":"C Kok","year":"2009","unstructured":"C. Kok, P.N. Sambrook, Secondary osteoporosis in patients with an osteoporotic fracture. Best. Pract. Res. Clin. Rheumatol. 23, 769\u2013779 (2009). https:\/\/doi.org\/10.1016\/j.berh.2009.09.006","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"2616_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1530\/EJE-10-0015","volume":"162","author":"LC Hofbauer","year":"2010","unstructured":"L.C. Hofbauer, C. Hamann, P.R. Ebeling, Approach to the patient with secondary osteoporosis. Eur. J. Endocrinol. 162, 1009\u20131020 (2010). https:\/\/doi.org\/10.1530\/EJE-10-0015","journal-title":"Eur. J. Endocrinol."},{"key":"2616_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"G Di Dalmazi","year":"2014","unstructured":"G. Di Dalmazi, V. Vicennati, S. Garelli, E. Casadio, E. Rinaldi, E. Giampalma, C. Mosconi, R. Golfieri, A. Paccapelo, U. Pagotto, R. Pasquali, Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2, 396\u2013405 (2014). https:\/\/doi.org\/10.1016\/S2213-8587(13)70211-0","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2616_CR15","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1210\/jc.2014-3007","volume":"99","author":"M Debono","year":"2014","unstructured":"M. Debono, M. Bradburn, M. Bull, B. Harrison, R.J. Ross, J. Newell-Price, Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J. Clin. Endocrinol. Metab. 99, 4462\u20134470 (2014). https:\/\/doi.org\/10.1210\/jc.2014-3007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2616_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","volume":"58","author":"J Patrova","year":"2017","unstructured":"J. Patrova, M. Kjellman, H. Wahrenberg, H. Falhammar, Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Endocrine 58, 267\u2013275 (2017). https:\/\/doi.org\/10.1007\/s12020-017-1400-8","journal-title":"Endocrine"},{"key":"2616_CR17","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/01.ATV.0000111245.75752.C6","volume":"24","author":"SM Grundy","year":"2004","unstructured":"S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr., C. Lenfant, Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Arterioscler. Thromb. Vasc. Biol. 24, e13\u2013e18 (2004). https:\/\/doi.org\/10.1161\/01.ATV.0000111245.75752.C6","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2616_CR18","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s00198-003-1521-1","volume":"14","author":"M Pedrazzoni","year":"2003","unstructured":"M. Pedrazzoni, G. Girasole, F. Bertoldo, G. Bianchi, C. Cepollaro, A. Del Puente, S. Giannini, S. Gonnelli, D. Maggio, C. Marcocci, S. Minisola, E. Palummeri, M. Rossini, L. Sartori, L. Sinigaglia, Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos. Int. 14, 978\u2013982 (2003). https:\/\/doi.org\/10.1007\/s00198-003-1521-1","journal-title":"Osteoporos. Int."},{"key":"2616_CR19","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"H.K. Genant, C.Y. Wu, C. van Kuijk, M.C. Nevitt, Vertebral fracture assessment using a semiquantitative technique. J. Bone Miner. Res. 8, 1137\u20131148 (1993). https:\/\/doi.org\/10.1002\/jbmr.5650080915","journal-title":"J. Bone Miner. Res."},{"key":"2616_CR20","doi-asserted-by":"publisher","first-page":"bvaa079","DOI":"10.1210\/jendso\/bvaa079","volume":"4","author":"C Eller-Vainicher","year":"2020","unstructured":"C. Eller-Vainicher, V. Morelli, C. Aresta, A.S. Salcuni, A. Falchetti, V. Carnevale, L. Persani, A. Scillitani, I. Chiodini, Defining nonfunctioning adrenal adenomas on the basis of the occurrence of hypocortisolism after adrenalectomy. J. Endocr. Soc. 4, bvaa079 (2020). https:\/\/doi.org\/10.1210\/jendso\/bvaa079","journal-title":"J. Endocr. Soc."},{"key":"2616_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000443862","volume":"46","author":"I Chiodini","year":"2016","unstructured":"I. Chiodini, V. Morelli, Subclinical hypercortisolism: how to deal with it? Front. Horm. Res. 46, 28\u201330 (2016)","journal-title":"Front. Horm. Res."},{"key":"2616_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2265.2008.03310.x","volume":"70","author":"I Chiodini","year":"2009","unstructured":"I. Chiodini, R. Viti, F. Coletti, G. Guglielmi, C. Battista, F. Ermetici, V. Morelli, A. Salcuni, V. Carnevale, F. Urbano, S. Muscarella, B. Ambrosi, M. Arosio, P. Beck-Peccoz, A. Scillitani, Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures. Clin. Endocrinol. 70, 208\u2013213 (2009). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03310.x","journal-title":"Clin. Endocrinol."},{"key":"2616_CR23","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/jbmr.398","volume":"26","author":"V Morelli","year":"2011","unstructured":"V. Morelli, C. Eller-Vainicher, A.S. Salcuni, F. Coletti, L. Iorio, G. Muscogiuri, S. Della Casa, M. Arosio, B. Ambrosi, P. Beck-Peccoz, I. Chiodini, Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J. Bone Miner. Res. 26, 1816\u20131821 (2011). https:\/\/doi.org\/10.1002\/jbmr.398","journal-title":"J. Bone Miner. Res."},{"key":"2616_CR24","unstructured":"ISTAT. Il Diabete in Italia (2017), https:\/\/www.istat.it\/it\/archivio\/202600. Accessed 20 July 2017"},{"key":"2616_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.afos.2019.05.001","volume":"5","author":"K Hygum","year":"2019","unstructured":"K. Hygum, J. Starup-Linde, B.L. Langdahl, Diabetes and bone. Osteoporos. Sarcopenia 5, 29\u201337 (2019). https:\/\/doi.org\/10.1016\/j.afos.2019.05.001","journal-title":"Osteoporos. Sarcopenia"},{"key":"2616_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1530\/eje.1.02045","volume":"153","author":"I Chiodini","year":"2005","unstructured":"I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur. J. Endocrinol. 153, 837\u2013844 (2005). https:\/\/doi.org\/10.1530\/eje.1.02045","journal-title":"Eur. J. Endocrinol."},{"key":"2616_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/jhh.2016.71","volume":"31","author":"G Tocci","year":"2017","unstructured":"G. Tocci, G. Nati, C. Cricelli, D. Parretti, F. Lapi, A. Ferrucci, C. Borghi, M. Volpe, Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database. J. Hum. Hypertens. 31, 258\u2013262 (2017). https:\/\/doi.org\/10.1038\/jhh.2016.71","journal-title":"J. Hum. Hypertens."},{"key":"2616_CR28","first-page":"393","volume":"40","author":"L Palmieri","year":"2004","unstructured":"L. Palmieri, S. Panico, D. Vanuzzo, M. Ferrario, L. Pilotto, R. Sega, G. Cesana, S. Giampaoli, La valutazione del rischio cardiovascolare globale assoluto: il punteggio individuale del Progetto CUORE [Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score]. Ann. Ist. Super. Sanita 40, 393\u2013399 (2004)","journal-title":"Ann. Ist. Super. Sanita"},{"key":"2616_CR29","unstructured":"Tognetto A, et al. Health status and quality of care in the Italian Regions. Italian Observatory on Healthcare Report (2016), https:\/\/www.osservatoriosullasalute.it\/osservasalute\/rapporto-osservasalute-2016. Accessed 18 Mar 2016"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02616-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02616-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02616-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T17:24:01Z","timestamp":1623950641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02616-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2616"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02616-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by local ethic committee and in accordance with Helsinki Declaration II.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants gave their witnessed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The Authors give their consent for publication of their work on Endocrine.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}